Valuation: Haleon plc

Market Cap 32.02B 42.65B 37.51B 34.89B 60.12B 4,117B 61.11B 415B 162B 2,019B 160B 157B 6,990B P/E 2026 *
18.8x
P/E 2027 * 17x
Enterprise Value 38.93B 51.86B 45.6B 42.43B 73.11B 5,006B 74.31B 504B 197B 2,455B 195B 190B 8,499B EV / Sales 2026 *
3.42x
EV / Sales 2027 * 3.23x
Free-Float
99.42%
Yield 2026 *
2.2%
Yield 2027 * 2.45%
1 day+0.53%
1 week-1.78%
Current month+4.54%
1 month+8.93%
3 months+3.38%
6 months-4.29%
Current year-3.01%
1 week 358.4
Extreme 358.4
373.1
1 month 344.2
Extreme 344.2
377.5
Current year 317.8
Extreme 317.8
416.1
1 year 274.4
Extreme 274.4
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 2021-07-21
Director of Finance/CFO 57 2024-10-31
Chief Tech/Sci/R&D Officer 63 2025-07-31
Director TitleAgeSince
Director/Board Member 59 2022-05-22
Chairman 71 2025-12-31
Director/Board Member 59 2022-07-17
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Tax

Chief Financial Officer

-133,301 0.0015%
6/30/26 Free

Chief Financial Officer

283,193 0.0032%
5/19/26 Others 4,415 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.53%-1.78%+1.39%+7.59% 42.39B
+0.86%+2.30%+49.71%+158.86% 1,057B
+1.59%+5.37%+55.77%+54.77% 624B
+0.95%+1.95%+36.11%+80.44% 454B
+1.60%+7.09%+35.90%+29.32% 341B
-0.60%+2.95%+36.28%+39.04% 297B
-0.14%+0.33%+18.70%+17.64% 262B
+0.09%-4.53%-27.60%-42.19% 215B
+1.22%+1.20%+21.61%+60.14% 201B
-1.18%-5.13%+13.87%+60.35% 162B
Average +0.24%+0.47%+24.17%+46.60% 365.63B
Weighted average by Cap. +0.13%+1.52%+36.21%+76.03%

Financials

2026 *2027 *
Net sales 11.4B 15.18B 13.35B 12.42B 21.4B 1,466B 21.76B 148B 57.82B 719B 56.96B 55.76B 2,488B 11.89B 15.84B 13.93B 12.96B 22.33B 1,529B 22.69B 154B 60.31B 750B 59.41B 58.17B 2,596B
Net income 1.74B 2.32B 2.04B 1.9B 3.27B 224B 3.33B 22.56B 8.84B 110B 8.71B 8.53B 380B 1.9B 2.53B 2.23B 2.07B 3.57B 244B 3.63B 24.61B 9.64B 120B 9.5B 9.3B 415B
Net Debt 6.91B 9.21B 8.1B 7.53B 12.98B 889B 13.19B 89.5B 35.07B 436B 34.55B 33.82B 1,509B 6.4B 8.53B 7.5B 6.98B 12.03B 823B 12.22B 82.9B 32.49B 404B 32B 31.33B 1,398B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (29.5%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (22.8%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (17.7%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - vitamins, minerals and food supplements (15.1%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. - respiratory medicines (14.9%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.2%), North America (36%), and Asia/Pacific (22.8%).
Employees
24,535
Date Price Change Volume
26-07-24 GBX 363.50 +0.53% 12,838,197
26-07-23 GBX 361.60 -1.18% 15,272,042
26-07-22 GBX 365.90 -0.73% 20,492,365
26-07-21 GBX 368.60 -0.65% 23,392,432
26-07-20 GBX 371.00 -0.62% 18,087,141
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.635GBP
Average target price
4.142GBP
Spread / Average Target
+13.96%

Quarterly revenue - Rate of surprise